单纯青光眼手术或联合白内障手术后角膜内皮细胞密度丢失:系统综述与Meta分析
该系统综述与Meta分析纳入39项研究,评估青光眼手术联合或不联合白内障手术后角膜内皮细胞密度(ECD)丢失。结果显示长期植入物相关手术ECD丢失较多,而小梁切除术12个月ECD丢失未达统计学显著,证据确定性多为低至极低。
要点
- 脉络膜上腔微创青光眼手术(MIGS)12个月平均ECD丢失282 cells/mm²(95%CI 220-345),证据确定性极低。
- Schlemm管植入装置12个月平均ECD丢失338 cells/mm²(95%CI 185-491),证据确定性低。
- 小梁切除术12个月平均ECD丢失33 cells/mm²(95%CI -38至105,P=0.36),未达统计学显著。
核心结论
- 总体而言,低确定性证据提示涉及长期植入物的青光眼手术比不使用植入物的青光眼滤过手术ECD丢失程度更大。
- 本综述结果支持在青光眼引流植入物植入后随访超过36个月以评估ECD丢失和角膜失代偿。
研究设计与样本
- 系统综述与Meta分析,纳入接受青光眼滤过手术或微创青光眼手术(MIGS)的眼压升高、原发性及继发性开角型青光眼、正常眼压性青光眼和闭角型青光眼患者。
- 检索数据库包括MEDLINE、Embase、Cochrane对照试验中心注册库、ClinicalTrials.gov、国际前瞻性系统综述注册库、美国食品药品监督管理局(FDA)上市前批准和FDA 510(k),检索时间为2021年12月。
- 共39项研究纳入定量合成。
主要发现
- 脉络膜上腔MIGS术后12个月平均ECD丢失282 cells/mm²(95%CI 220-345;P < 0.00001;卡方=0.06;I²=0%;2项研究;证据确定性极低)。
- Schlemm管植入装置术后12个月平均ECD丢失338 cells/mm²(95%CI 185-491;P < 0.0001;卡方=0.08;I²=0%;2项研究;证据确定性低)。
- Schlemm管手术(不使用植入装置)术后12个月平均ECD丢失64 cells/mm²(95%CI 21-107;P = 0.004;卡方=4.55;I²=0%;6项研究;证据确定性低)。
- 小梁切除术术后12个月平均ECD丢失33 cells/mm²(95%CI -38至105;P = 0.36;卡方=1.17;I²=0%;证据确定性中等)。
- Express(Alcon)植入术后12个月平均ECD丢失121 cells/mm²(95%CI 53-189;P = 0.0005;卡方=3.00;I²=0%;5项研究;证据确定性低)。
关键数值与推荐
- 脉络膜上腔MIGS术后12个月平均ECD丢失282 cells/mm²(95%CI 220-345;P < 0.00001;卡方=0.06;I²=0%;2项研究;证据确定性极低)。
- Schlemm管植入装置术后12个月平均ECD丢失338 cells/mm²(95%CI 185-491;P < 0.0001;卡方=0.08;I²=0%;2项研究;证据确定性低)。
- Schlemm管手术(不使用植入装置)术后12个月平均ECD丢失64 cells/mm²(95%CI 21-107;P = 0.004;卡方=4.55;I²=0%;6项研究;证据确定性低)。
- 小梁切除术术后12个月平均ECD丢失33 cells/mm²(95%CI -38至105;P = 0.36;卡方=1.17;I²=0%;证据确定性中等)。
- Express(Alcon)植入术后12个月平均ECD丢失121 cells/mm²(95%CI 53-189;P = 0.0005;卡方=3.00;I²=0%;5项研究;证据确定性低)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 脉络膜上腔MIGS术后12个月ECD丢失的证据确定性为极低。
- Schlemm管植入装置、Schlemm管手术(不使用植入装置)和Express植入术后12个月ECD丢失的证据确定性为低。
- 房水引流管手术与对侧对照眼比较的12个月和24个月ECD丢失证据确定性为低。
- 24个月房水引流管手术与对侧对照眼比较的ECD丢失分析中异质性I²=48%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
TOPIC: Corneal endothelial cell density (ECD) loss after glaucoma surgery with or without cataract surgery. CLINICAL RELEVANCE: Corneal ECD loss may occur as the result of intraoperative surgical trauma in glaucoma surgery or postoperatively with chronic endothelial cell trauma or irritation. METHODS: Glaucoma filtration surgery or microinvasive glaucoma surgery (MIGS) in participants with ocular hypertension, primary and secondary open-angle glaucoma, normal-tension glaucoma, and angle-closure glaucoma were included. Electronic databases searched in December 2021 included MEDLINE, Embase, Cochrane Central Register of Controlled Trials, ClinicalTrials.gov, the International Prospective Register of Systematic Reviews, Food and Drug Administration (FDA) Premarket Approval, and FDA 510(k). RESULTS: A total of 39 studies were included in quantitative synthesis. Twelve months after suprachoroidal MIGS, mean ECD loss was 282 cells/mm2 (95% confidence interval [CI], 220-345; P < 0.00001; chi-square = 0.06; I2 = 0%; 2 studies; very low certainty). Mean ECD loss after Schlemm's canal implantable devices was 338 cells/mm2 (95% CI, 185-491; P < 0.0001; chi-square = 0.08; I2 = 0%; 2 studies; low certainty) at 12 months. Mean ECD loss was 64 cells/mm2 (95% CI, 21-107; P = 0.004; chi-square = 4.55; I2 = 0%; 6 studies; low certainty) after Schlemm's canal procedures (without implantable devices) at 12 months. At 12 months, the mean ECD loss after trabeculectomy was 33 cells/mm2 (95% CI, -38 to 105, P = 0.36, chi-square = 1.17; I2 = 0%; moderate certainty). At 12 months, mean ECD loss was 121 cells/mm2 (95% CI, 53-189; P = 0.0005; chi-square = 3.00; I2 = 0%; 5 studies; low certainty) after Express (Alcon) implantation. When compared with the control fellow eye, aqueous shunt surgery reduced ECD by 5.75% (95% CI, -0.93 to 12.43; P = 0.09, chi-square = 1.32; I2 = 0%; low certainty) and 8.11% ECD loss (95% CI, 0.06-16.16 P = 0.05; chi-square = 1.93; I2 = 48%) at 12 and 24 months, respectively. CONCLUSIONS: Overall, there is low certainty evidence to suggest that glaucoma surgery involving long-term implants has a greater extent of ECD loss than glaucoma filtration surgeries without the use of implants. The results of this review support follow-up beyond 36 months to assess ECD loss and corneal decompensation after implantation of glaucoma drainage implants.
引用
- Fang CEH, Mathew RG, Khaw PT, et al. Corneal Endothelial Cell Density Loss after Glaucoma Surgery Alone or in Combination with Cataract Surgery: A Systematic Review and Meta-analysis. Ophthalmology. 2022. PMID: 35331751. doi:10.1016/j.ophtha.2022.03.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。